Literature DB >> 19891056

A review of human carcinogens--Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish.

Béatrice Secretan, Kurt Straif, Robert Baan, Yann Grosse, Fatiha El Ghissassi, Véronique Bouvard, Lamia Benbrahim-Tallaa, Neela Guha, Crystal Freeman, Laurent Galichet, Vincent Cogliano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19891056     DOI： 10.1016/s1470-2045(09)70326-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  324 in total

1.  Current status of esophageal endoscopy including the evaluation of smoking and alcohol consumption in Japan: an analysis based on the Japan endoscopy database.

Authors:  Chikatoshi Katada; Takahiro Horimatsu; Manabu Muto; Kiyohito Tanaka; Koji Matsuda; Mitsuhiro Fujishiro; Yutaka Saito; Kazuo Ohtsuka; Ichiro Oda; Masayuki Kato; Mitsuhiro Kida; Kiyonori Kobayashi; Shu Hoteya; Shinya Kodashima; Takahisa Matsuda; Hironori Yamamoto; Shomei Ryozawa; Ryuichi Iwakiri; Hiromu Kutsumi; Hiroaki Miyata; Mototsugu Kato; Ken Haruma; Kazuma Fujimoto; Naomi Uemura; Michio Kaminishi; Hisao Tajiri
Journal:  Esophagus       Date:  2018-12-05       Impact factor: 4.230

2.  N-acetyltransferase 2 polymorphisms, tobacco smoking, and breast cancer risk in the breast and prostate cancer cohort consortium.

Authors:  David G Cox; Lucie Dostal; David J Hunter; Loïc Le Marchand; Robert Hoover; Regina G Ziegler; Michael J Thun
Journal:  Am J Epidemiol       Date:  2011-11-10       Impact factor: 4.897

3.  Time course of DNA adduct formation in peripheral blood granulocytes and lymphocytes after drinking alcohol.

Authors:  Silvia Balbo; Lei Meng; Robin L Bliss; Joni A Jensen; Dorothy K Hatsukami; Stephen S Hecht
Journal:  Mutagenesis       Date:  2012-03-09       Impact factor: 3.000

4.  Metabolism of [D10]phenanthrene to tetraols in smokers for potential lung cancer susceptibility assessment: comparison of oral and inhalation routes of administration.

Authors:  Yan Zhong; Jing Wang; Steven G Carmella; J Bradley Hochalter; Diane Rauch; Andrew Oliver; Joni Jensen; Dorothy K Hatsukami; Pramod Upadhyaya; Cheryl Zimmerman; Stephen S Hecht
Journal:  J Pharmacol Exp Ther       Date:  2011-04-22       Impact factor: 4.030

5.  Cancer history and risk factors in healthy older people enrolling in the ASPREE clinical trial.

Authors:  Suzanne G Orchard; Jessica E Lockery; Peter Gibbs; Galina Polekhina; Rory Wolfe; John Zalcberg; Andrew Haydon; John J McNeil; Mark R Nelson; Christopher M Reid; Brenda Kirpach; Anne M Murray; Robyn L Woods
Journal:  Contemp Clin Trials       Date:  2020-07-31       Impact factor: 2.226

Review 6.  Global trends of lung cancer mortality and smoking prevalence.

Authors:  Farhad Islami; Lindsey A Torre; Ahmedin Jemal
Journal:  Transl Lung Cancer Res       Date:  2015-08

7.  Cancer incidence among Minnesota taconite mining industry workers.

Authors:  Elizabeth M Allen; Bruce H Alexander; Richard F MacLehose; Heather H Nelson; Gurumurthy Ramachandran; Jeffrey H Mandel
Journal:  Ann Epidemiol       Date:  2015-08-29       Impact factor: 3.797

8.  Genome-Wide CRISPR Screening Identifies the Tumor Suppressor Candidate OVCA2 As a Determinant of Tolerance to Acetaldehyde.

Authors:  Amin Sobh; Alex Loguinov; Alessia Stornetta; Silvia Balbo; Abderrahmane Tagmount; Luoping Zhang; Chris D Vulpe
Journal:  Toxicol Sci       Date:  2019-05-01       Impact factor: 4.849

Review 9.  "Quitting smoking will benefit your health": the evolution of clinician messaging to encourage tobacco cessation.

Authors:  Benjamin A Toll; Alana M Rojewski; Lindsay R Duncan; Amy E Latimer-Cheung; Lisa M Fucito; Julie L Boyer; Stephanie S O'Malley; Peter Salovey; Roy S Herbst
Journal:  Clin Cancer Res       Date:  2014-01-16       Impact factor: 12.531

Review 10.  Mendelian randomization in cardiometabolic disease: challenges in evaluating causality.

Authors:  Michael V Holmes; Mika Ala-Korpela; George Davey Smith
Journal:  Nat Rev Cardiol       Date:  2017-06-01       Impact factor: 32.419
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.